Pippa G Corrie

24PUBLICATIONS
133CO-AUTHORS
Predictive and prognostic markersSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 02, 2025
MANIFEST: Multiomic Platform for Cancer Immunotherapy.

Kok Haw Jonathan Lim, Zayd Tippu, Pippa G Corrie

|Apr 26, 2024
Curing Stage IV Melanoma: Where Have We Been and Where Are We?

Pui Ying Chan, Pippa G Corrie

|Jun 12, 2023
First-Line, Fixed-Duration Nivolumab Plus Ipilimumab Followed by Nivolumab in Clinically Diverse Patient Populations With Unresectable Stage III or IV Melanoma: CheckMate 401.

Reinhard Dummer, Pippa Corrie, Ralf Gutzmer

|Mar 24, 2023
The impact of the COVID-19 pandemic upon pancreatic cancer treatment (CONTACT Study): a UK national observational cohort study.

Lewis A Hall, Siobhan C McKay, James Halle-Smith

|Feb 22, 2023
Clinical and biological markers predictive of treatment response associated with metastatic pancreatic adenocarcinoma.

Alimu Dayimu, Lorena Di Lisio, Shubha Anand

Pageof 4